SCHEMBL6441719

SCHEMBL6441719

O=C1C=c2nccnc2=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28537246 0.71 TDP2 (0.31)
SCHEMBL5741659 0.66 ALDH1A1 (0.30)
SCHEMBL5741655 0.66 ALDH1A1 (0.30)
SCHEMBL16026405 0.66 MAPT (0.39)
SCHEMBL31666410 0.65
SCHEMBL28501744 0.64
SCHEMBL9920588 0.64
SCHEMBL10172943 0.64
SCHEMBL8871276 0.60
SCHEMBL13134287 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113698413-B Coumarin derivative SS-590 as well as preparation method and application thereof 山西大学 2022-07-19 CN disclosed
CN-113698413-B Coumarin derivative SS-590 as well as preparation method and application thereof 山西大学 2022-07-19 CN disclosed
CN-109761986-B Tricyclic derivative inhibitor, preparation method and application thereof 上海翰森生物医药科技有限公司 2021-10-08 CN disclosed
EP-1561753-A2 Benzo[b]chromenonapthyridin-7-one and pyrano[2',3':7,8]quino[2,3-b]Quinoxalin-7-one derivatives, process of synthesis, pharmaceutical compositions and their antitumoral properties for the treatment of cancer Les Laboratoires Servier (FR) 2005-08-10 EP disclosed